Insight Molecular Diagnostics Inc.

IMDX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.01

+$0.01 (+0.25%)

At close: Sep 21, 2026, 4:00 PM ET

$3.88

-$0.13 (-3.24%)

Pre-market: Sep 22, 2026, 4:01 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.25%

(1D)

Rating

Updated: Sep 8, 2026

31.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $129.48M

1D Range

3.86 4.09

52W Range

2.42 8.51

Valuation (TTM)

PE -2.64

PB -6.08

EV/EBITDA -2.44

Valuation (NTM)

Forward PE N/A

Forward PEG 0.55

Price Target $9.75

Cash Flow

FCF Yield -23.8%

SBC Adj. FCF Yield -25.8%

SBC Impact -8.3%

Margins

Gross Margin 11.2%

Operating Margin -2558.7%

FCF Margin -1848.8%

Growth (CAGR)

Revenue 3Y | 5Y 14.9% | -16.9%

Dil EPS 3Y | 5Y 44.4% | 48.1%

FCF 3Y | 5Y -28.8% | 14.3%

Returns

ROA -167.6%

ROE 271.8%

ROIC -204.8%

Financial Health

Net Cash

$15.13M

Current Ratio 2.00

Interest Coverage -436.03

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identificat...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 57

IPO Date Dec 29, 2015

Website imdxinc.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$9.50

Upside

+136.91%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞